PHILADELPHIA – According to a study that appears in the current issue of SCAN (Social Cognitive and Affective Neuroscience), researchers at the University of Pennsylvania School of Medicine discuss how men and women differ in their neural responses to psychological stress.
“We found that different parts of the brain activate with different spatial and temporal profiles for men and women when they are faced with performance-related stress,” says J.J. Wang, PhD, Assistant Professor or Radiology and Neurology, and lead author of the study.
These findings suggest that stress responses may be fundamentally different in each gender, sometimes characterized as “fight-or-flight” in men and “tend-and-befriend” in women. Evolutionarily, males may have had to confront a stressor either by overcoming or fleeing it, while women may have instead responded by nurturing offspring and affiliating with social groups that maximize the survival of the species in times of adversity. The “fight-or-flight” response is associated with the main stress hormone system that produces cortisol in the human body – the hypothalamic-pituitary-adrenal (HPA) axis.
Thirty-two healthy subjects – 16 females and 16 males – received fMRI (functional Magnetic Resonance Imaging) scans before, during and after they underwent a challenging arithmetic task (serial subtraction of 13 from a 4 digit number), under pressure. To increase the level of stress, the researchers frequently prompted participants for a faster performance and asked them to restart the task if they responded incorrectly. As a low stress control condition, participants were asked to count backward without pressure.
The researchers measured heart rate, cortisol levels (a stress hormone), subjects’ perceived stress levels throughout the experiments, and regional cerebral blood flow (CBF), which provides a marker of regional brain function. In men, it was found that stress was associated with increased CBF in the right prefrontal cortex and CBF reduction in the left orbitofrontal cortex. In women, the limbic system – a part of the brain primarily involved in emotion – was activated when they were under stress. Both men and women’s brain activation lasted beyond the stress task, but the lasting response in the female brain was stronger. The neural response among the men was associated with higher levels of cortisol, whereas women did not have as much association between brain activation to stress and cortisol changes.
“Women have twice the rate of depression and anxiety disorders compared to men,” notes Dr. Wang. “Knowing that women respond to stress by increasing activity in brain regions involved with emotion, and that these changes last longer than in men, may help us begin to explain the gender differences in the incidence of mood disorders.”
Additional researchers involved with this study are Marc Korczykowski, Penn; Hengyi Rao, Penn; Yong Fan, Penn; John Pluta, Penn; Ruben Gur, Penn; Bruce McEwen, The Rockefeller University; and John Detre, Penn. This study was conducted at the Center for Functional Neuroimaging at the University of Pennsylvania.
PENN Medicine is a $3.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and excellence in patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is currently ranked #3 in the nation in U.S.News & World Report's survey of top research-oriented medical schools; and, according to most recent data from the National Institutes of Health, received over $379 million in NIH research funds in the 2006 fiscal year. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals — its flagship hospital, the Hospital of the University of Pennsylvania, rated one of the nation’s “Honor Roll” hospitals by U.S.News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center — a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.